Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances
Amit Bar‐Or, Rui Li
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 470-483
Closed Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity
Chang H. Kim
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 4, pp. 341-350
Closed Access | Times Cited: 131
Bruton tyrosine kinase inhibitors for multiple sclerosis
Julia Krämer, Amit Bar‐Or, Timothy J. Turner, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 5, pp. 289-304
Open Access | Times Cited: 99
Bone marrow hematopoiesis drives multiple sclerosis progression
Kaibin Shi, Handong Li, Ting Chang, et al.
Cell (2022) Vol. 185, Iss. 13, pp. 2234-2247.e17
Open Access | Times Cited: 88
Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
Rongzeng Liu, Shushu Du, Lili Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 79
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
Anne H. Cross, Jeffrey M. Gelfand, Simon Thebault, et al.
JAMA Neurology (2024) Vol. 81, Iss. 4, pp. 373-373
Open Access | Times Cited: 35
B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases
Aiden Haghikia, Georg Schett, Dimitrios Mougiakakos
The Lancet Neurology (2024) Vol. 23, Iss. 6, pp. 615-624
Open Access | Times Cited: 21
Thinking outside the box: non-canonical targets in multiple sclerosis
Laura Bierhansl, Hans‐Peter Hartung, Orhan Aktaş, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 8, pp. 578-600
Open Access | Times Cited: 68
TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications
Jian Luo
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1206-1206
Open Access | Times Cited: 60
BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy
Rui Li, Hao Tang, Jeremy C. Burns, et al.
Acta Neuropathologica (2022) Vol. 143, Iss. 4, pp. 505-521
Open Access | Times Cited: 47
Emerging therapies to target CNS pathophysiology in multiple sclerosis
Jiwon Oh, Amit Bar‐Or
Nature Reviews Neurology (2022) Vol. 18, Iss. 8, pp. 466-475
Closed Access | Times Cited: 43
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
Koji Shinoda, Rui Li, Ayman Rezk, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 3
Open Access | Times Cited: 35
Differential impact of environmental factors on systemic and localized autoimmunity
Hanane Touil, Kristin Mounts, Philip L. De Jager
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
Chi‐Yan Lee, Koon‐Ho Chan
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 120-120
Open Access | Times Cited: 15
Sex difference in human diseases: mechanistic insights and clinical implications
Yuncong Shi, Jianshuai Ma, Sijin Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Patterns of autoantibody expression in multiple sclerosis identified through development of an autoantigen discovery technology
Europe B DiCillo, Evgueni Kountikov, Minghua Zhu, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 5
Open Access | Times Cited: 1
Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis
Ute‐Christiane Meier, Richard Christopher Cipian, Abbas Karimi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 49
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
Amit Bar‐Or, Susan O’Brien, Michael Sweeney, et al.
CNS Drugs (2021) Vol. 35, Iss. 9, pp. 985-997
Open Access | Times Cited: 45
The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
Aigli G. Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8077-8077
Open Access | Times Cited: 36
Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis
Marina Rode von Essen, R. Hansen, Camilla Kaae Højgaard, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 4
Open Access | Times Cited: 34
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age
Leah Zuroff, Ayman Rezk, Koji Shinoda, et al.
EBioMedicine (2022) Vol. 82, pp. 104179-104179
Open Access | Times Cited: 32
Contribution of B cells to cortical damage in multiple sclerosis
Pavan Bhargava, Hans-Peter Hartung, Peter A. Calabresi
Brain (2022) Vol. 145, Iss. 10, pp. 3363-3373
Open Access | Times Cited: 29
B cell targeted therapies in inflammatory autoimmune disease of the central nervous system
Moritz J. Furman, Sven G. Meuth, Philipp Albrecht, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases
Yiyue Zhang, Xisheng Li, Kaidi Ren, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101931-101931
Closed Access | Times Cited: 19
The roles of Th cells in myocardial infarction
Jun Liu, Feila Liu, Tingting Liang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease
Rui Li, Thomas F. Tropea, Laura Rosa Baratta, et al.
Neurology Neuroimmunology & Neuroinflammation (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top